Immunological mechanisms of mRNA vaccines for infectious diseases

Hogan, M. J. & Pardi, N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu. Rev. Med. 73 , 17–39 (2022). Article CAS PubMed Google Scholar Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal Transduct. Target. Ther. 8 , 365 (2023). Article CAS PubMed PubMed Central Google Scholar Sahin, U., Kariko, K. & Tureci, O. mRNA-based therapeutics—developing a new class of drugs. Nat. Rev. Drug Discov. 13 , 759–780 (2014). Article CAS PubMed Google Scholar Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20 , 817–838 (2021). Article CAS PubMed PubMed Central Google Scholar Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases—advances, challenges and opportunities. Nat. Rev. Drug Discov. 23 , 838–861 (2024). Article CAS PubMed PubMed Central Google Scholar Srivastava, K. et al. SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity 57 , 587–599 (2024). Article CAS PubMed PubMed Central Google Scholar Zhang, Z. L. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185 , 2434–2451 (2022). Article CAS PubMed PubMed Central Google Scholar Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596 , 410–416 (2021). …